Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:06 PM ET 8-K
Nasdaq/NYSE Compliance Notice Mustang Bio, Inc. MBIO

Mustang Bio Nasdaq/NYSE Compliance Notice

Mustang Bio received a second 180-day grace period from Nasdaq, until April 12, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company intends to monitor its stock price and may effect a reverse stock split if necessary to maintain its listing on the Nasdaq Capital Market.

Counterparty
Nasdaq
Term
180 days
4:02 PM ET 8-K
M&A Deal Andersen Group Inc. ANDG

Andersen Group M&A Deal with Andersen Servicios Profesionales

Andersen Group Inc. announced the acquisition of five professional services and consulting firms: Andersen Servicios Profesionales, BD Emerson, Daniels Consulting Group, Endeavor Management, and Clareo Consulting. The transactions involve a mix of cash and the issuance of Class A common stock as consideration, with two deals already closed and three expected to close by Q1 2027.

Counterparty
Andersen Servicios Profesionales, S.C.; BD Emerson LLC; DCG Holdco, Inc.; E4 Holdco LLC; Clareo Consulting, LLC
4:02 PM ET 8-K
Capital Raise Grayscale Stellar Lumens Trust (XLM) GXLM

Grayscale Stellar Lumens Trust Capital Raise of $1.14M

Grayscale Stellar Lumens Trust issued 73,400 shares in private placement transactions to accredited investors for an aggregate of approximately 6.06 million XLM, valued at $1,136,743. The shares were issued at varying prices based on the Trust's NAV per share, bringing the total shares outstanding to 1,462,600.

Value
$1.14M
Counterparty
accredited investors
1:00 PM ET 8-K
Capital Raise GM Financial Consumer Automobile Receivables Trust 2026-4

GM Financial Consumer Automobile Receivables Trust 2026-4 Capital Raise of $1.02B

GM Financial Consumer Automobile Receivables Trust 2026-4 completed the issuance of $1.016 billion in asset-backed notes across several classes (A-1 through C). The notes are backed by a pool of prime automobile loan contracts and were sold to a syndicate of underwriters led by SMBC Nikko Securities America.

Value
$1.02B
Counterparty
SMBC Nikko Securities America, Inc.
9:30 AM ET 8-K
Partnership iPower Inc. IPW

iPower Partnership Worth $21.9M

iPower Inc. announced that its subsidiary, iPower AI LLC, received a customer-signed, non-binding letter of intent for a five-year AI equipment services and management relationship. The deal contemplates an expansion from 48 to 396 AI computing units, potentially generating up to $21.90 million in annualized service fees.

Value
$21.9M
Term
5 years
9:30 AM ET 8-K
Clinical Trial Data bioAffinity Technologies, Inc. BIAF

bioAffinity Technologies Clinical Trial Data

bioAffinity Technologies announced it will present positive research data at the CHEST 2026 annual meeting regarding its CyPath Lung test and a new investigational test for asthma and COPD-related lung inflammation. The presentation will focus on improving lung cancer risk stratification and managing pulmonary nodules using the company's noninvasive flow cytometry technology.

Counterparty
American College of Chest Physicians
9:26 AM ET 8-K
Capacity Expansion Evolution Metals & Technologies Corp. EMAT

Evolution Metals & Technologies Capacity Expansion

Evolution Metals & Technologies Corp. has begun taking delivery of 13 ULVAC machines at its Pohang, South Korea facility, part of a 57-container shipment to expand production. The expansion is expected to increase the company's annual rare earth magnet capacity ten-fold from 1,000 to 10,000 metric tons. This move positions EM&T as the largest producer of rare earth permanent magnets outside of China ahead of new U.S. defense procurement regulations.

Counterparty
ULVAC
9:16 AM ET 8-K
Nasdaq/NYSE Compliance Notice Quantum-Si Inc QSI

Quantum-Si Nasdaq/NYSE Compliance Notice

Quantum-Si Incorporated has regained compliance with Nasdaq's minimum bid price requirement as its Class A common stock maintained a closing bid price of at least $1.00 per share for 10 consecutive business days. The company had previously received a deficiency notice on July 23, 2026, and Nasdaq has now officially closed the matter.

Counterparty
Nasdaq
8:50 AM ET 8-K
M&A Deal Beazer Homes USA Inc BZH

Beazer Homes USA M&A Deal with Dream Finders Homes, Inc.

Beazer Homes USA stockholders approved the previously announced merger agreement with Dream Finders Homes, Inc. at a special meeting held on October 15, 2026. Under the terms of the agreement, Beazer Homes will become a wholly owned subsidiary of Dream Finders Homes, with the closing expected to occur three business days after final conditions are met.

Counterparty
Dream Finders Homes, Inc.
8:47 AM ET 8-K
Capital Raise Recursion Pharmaceuticals, Inc. RXRX

Recursion Pharmaceuticals Capital Raise of $200M

Recursion Pharmaceuticals entered into an underwriting agreement to raise approximately $200 million through a public offering of 61,540,000 shares of Class A common stock at $3.25 per share. The company also announced that Sanofi exercised an option for a first-in-class immunology development candidate under their existing collaboration, triggering a $10 million milestone payment. Proceeds from the equity raise are expected to extend the company's cash runway into 2029.

Value
$200M
Counterparty
Leerink Partners LLC
8:46 AM ET 8-K
M&A Deal Vivos Therapeutics, Inc. VVOS

Vivos Therapeutics Signs $12M M&A Deal with SOD Sciences, Inc.

Vivos Therapeutics entered into a definitive agreement to acquire an 11% equity stake in SOD Sciences and a 50% co-ownership interest in a proprietary pseudohypoxia early-warning test. The transaction is valued at $12 million, paid via the issuance of 12,000 shares of newly created Series C Convertible Preferred Stock, and is intended to bolster stockholders' equity for Nasdaq compliance.

Value
$12M
Counterparty
SOD Sciences, Inc.
8:42 AM ET 8-K
M&A Deal AtlasClear Holdings, Inc. ATCH

AtlasClear Holdings Signs $24.5M M&A Deal with Ark Financial Services, Inc.

AtlasClear Holdings has entered into a definitive agreement to acquire Ark Financial Services, the parent of investment bank Dawson James Securities, for up to $24.5 million in cash and stock. The company concurrently completed an initial 24.9% equity purchase for $5 million, with the remaining 75.1% acquisition subject to FINRA approval and other closing conditions. The deal aims to integrate a nationally ranked small-cap investment bank into AtlasClear's clearing platform, more than doubling the company's combined pro forma revenue.

Value
$24.5M
Counterparty
Ark Financial Services, Inc.
8:32 AM ET 8-K
M&A Deal Pyrophyte Acquisition Corp. II PAII

Pyrophyte Acquisition Corp. II Signs $600M M&A Deal with Sakuu Corporation

Pyrophyte Acquisition Corp. II (NYSE: PAII) entered into a definitive business combination agreement to acquire Sakuu Corporation, a Silicon Valley-based energy storage manufacturing technology company. The transaction implies a pre-money equity value of $600 million for Sakuu, with the combined company expected to list on the NYSE under the ticker 'SAKU'.

Value
$600M
Counterparty
Sakuu Corporation

“Kavian technology is not only the world’s first additive manufacturing solution to dry print high-performance battery electrodes at scale; it can also dry print supercapacitor electrodes customized for the growing power needs of AI data centers. It is the only known solution for producing heavily in-demand energy products that can be custom-printed rapidly, sustainably, and cost-effectively.”

Robert Bagheri, Sakuu Founder and Chief Executive Officer
8:30 AM ET 8-K
Partnership OpenWorld, Inc. OPNW

OpenWorld Partnership with Meridian Worth $1B

OpenWorld signed a non-binding term sheet with Meridian to establish a $1 billion tokenized financing program for a distributed AI computing network powered by solar energy and Tesla Powerwall batteries. OpenWorld will serve as the structuring agent and operator for the network, which aims to deploy compute nodes across 10,000 homes and commercial sites starting in Q4 2026.

Value
$1B
Counterparty
Meridian
8:23 AM ET 8-K
Partnership ASP Isotopes Inc. ASPI

ASP Isotopes Partnership with Nuclear Energy Corporation of South Africa SOC Limited

ASP Isotopes' subsidiary Quantum Leap Energy (QLE) signed a binding Heads of Agreement with Necsa to form a joint venture (80% QLE / 20% Necsa) to develop and operate a commercial-scale HALEU production facility in South Africa. The venture will utilize QLE's enrichment technology and Necsa's Pelindaba site infrastructure, supported by existing offtake agreements with TerraPower.

Counterparty
Nuclear Energy Corporation of South Africa SOC Limited (Necsa)
8:17 AM ET 8-K
M&A Deal CCC Intelligent Solutions Holdings Inc. CCC

CCC Intelligent Solutions Holdings Signs $6.1B M&A Deal with GTCR and Elliott Investment Management L.P.

CCC Intelligent Solutions Holdings Inc. has entered into a definitive agreement to be acquired by a consortium led by GTCR and Elliott Investment Management in an all-cash transaction valued at approximately $6.1 billion. Stockholders will receive $7.75 per share in cash, representing a 44% premium to the company's unaffected closing price. The deal is expected to close in the first quarter of 2027, at which point CCC will become a privately held company.

Value
$6.1B
Counterparty
GTCR and Elliott Investment Management L.P.
8:00 AM ET 8-K
Clinical Trial Data Jasper Therapeutics, Inc. JSPR

Jasper Therapeutics Clinical Trial Data

Jasper Therapeutics completed enrollment for the IgA nephropathy (IgAN) cohort of its Phase 2 basket study evaluating vensobafusp alfa (KP104). The company expects to report initial interim data from this study by year-end 2026 and plans to expand the study to include patients with focal segmental glomerulosclerosis (FSGS) in early 2027.

7:30 AM ET 8-K
Divestiture Gibraltar Industries, Inc. ROCK

Gibraltar Industries Divestiture to GCP Applied Technologies Inc. for $208M

Gibraltar Industries has entered into a definitive agreement to sell its Infrastructure business, The D.S. Brown Company, to GCP Applied Technologies (an affiliate of Saint-Gobain) for $208 million in cash. The divestiture is part of a strategic plan to simplify the company's portfolio and focus on building products and structures, with proceeds intended for debt reduction.

Value
$208M
Counterparty
GCP Applied Technologies Inc. (Saint-Gobain Corporation)
7:02 AM ET 8-K
Clinical Trial Data Krystal Biotech, Inc. KRYS

Krystal Biotech Clinical Trial Data

Krystal Biotech announced positive proof-of-concept clinical data from its Gorlin Syndrome Pilot Study evaluating KB113 for the treatment of basal cell carcinomas. The study showed that over 80% of assessed lesions regressed across three patients, including non-injected lesions, suggesting a systemic abscopal effect.

7:02 AM ET 8-K
M&A Deal Cronos Group Inc. CRON

Cronos Group M&A Deal with CanAdelaar B.V.

Cronos Group completed the acquisition of CanAdelaar B.V., a licensed cannabis grower in the Dutch Controlled Cannabis Supply Chain Experiment, for a base purchase price of €57.5 million plus earnouts. The deal establishes Cronos' European platform in the Netherlands' adult-use cannabis pilot program, with the buyer deducting €12.5 million from the initial price to cover a potential environmental penalty.

Counterparty
CanAdelaar B.V.
7:01 AM ET 8-K/A
M&A Deal Esquire Financial Holdings, Inc. ESQ

Esquire Financial Holdings M&A Deal with Signature Bancorporation, Inc.

Esquire Financial Holdings, Inc. completed its merger with Signature Bancorporation, Inc. on August 1, 2026, following a definitive agreement signed in March 2026. This filing serves as an amendment to provide required pro forma financial information showing the combined entity's financial condition as of March 31, 2026.

Counterparty
Signature Bancorporation, Inc.
7:00 AM ET 8-K
M&A Deal Penske Automotive Group, Inc. PAG

Penske Automotive Group Signs $16.3B M&A Deal with Penske Corporation and Mitsui & Co., Ltd.

Penske Automotive Group (PAG) has entered into a definitive merger agreement to be taken private by an investor group led by Penske Corporation and Mitsui & Co. for $212.00 per share in cash. The transaction values the company at an enterprise value of approximately $16.3 billion and represents an 8.84% premium to the prior day's closing price. Upon completion, expected in Q1 2027, PAG will be owned 64% by Penske and 36% by Mitsui.

Value
$16.3B
Counterparty
Penske Corporation and Mitsui & Co., Ltd.
6:27 AM ET 8-K
Capacity Expansion Venture Global, Inc. VG

Venture Global Capacity Expansion: $17.2B Investment

Venture Global entered into frame agreements with GE Vernova and Baker Hughes for the supply of up to 16 power islands and associated grid equipment to support over 10 GW of new Island-Mode power capacity. The $17.2 billion framework is designed to support the expansion of the company's LNG business and the development of adjacent, behind-the-meter large-scale data centers. This vertically integrated strategy aims to provide gigawatt-scale compute capacity without reliance on the public electric grid.

Value
$17.2B
Counterparty
GE Vernova and Baker Hughes
Term
through 2034

“By providing Island-Mode power generation, gas supply, closed-loop water systems, thousands of acres of land, data centers, and other necessary infrastructure, Venture Global is creating a vertically integrated AI utility that could solve for the many chokepoints associated with the AI buildout.”

Mike Sabel, Venture Global CEO
6:07 AM ET 8-K
M&A Deal Roku, Inc ROKU

Roku M&A Deal with Fox Corporation

Roku stockholders voted to approve the previously announced merger agreement with Fox Corporation, with 81.5% of outstanding shares voting in favor of the deal. Under the terms of the agreement, Roku will become a wholly owned subsidiary of Fox. Stockholders also approved the merger-related executive compensation proposal on an advisory basis.

Counterparty
Fox Corporation
6:07 AM ET 8-K
Licensing Deal Ocugen, Inc. OCGN

Ocugen Licensing Deal with Roots Pharmaceutical Company WLL Worth $259M

Ocugen granted Roots Pharmaceutical an exclusive license to commercialize OCU400, a modifier gene therapy for retinitis pigmentosa, in the Middle East and North Africa. Ocugen will receive up to $4 million in upfront and development milestones, up to $255 million in sales milestones, and a 22% royalty on net sales. Ocugen also entered into a commercial supply agreement to manufacture the product for Roots.

Value
$259M
Counterparty
Roots Pharmaceutical Company WLL
Term
20 years from first commercial sale
6:06 AM ET 8-K
Contract Win Exascale Labs Holdings Inc. XLAB

Exascale Labs Holdings Wins $8.21M Contract from Sunon Inc.

Exascale Labs Holdings Inc. entered into a purchase and sale agreement with Sunon Inc. to provide 12 NVIDIA HGX B300 GPU servers (96 GPUs) and related networking equipment. The $8.2 million contract includes deployment services and 36 months of IT operation services for a U.S.-based data center.

Value
$8.21M
Counterparty
Sunon Inc.
Term
36 months
5:28 PM ET 8-K
Divestiture Zone Frontier Inc. ZONE

Zone Frontier Divestiture to Sanzonate Holdings LLC for $3.35M

Zone Frontier Inc. sold substantially all assets of its legacy Cleaning Products Business, including its Irish subsidiary CleanCore Global Limited, to Sanzonate Holdings LLC for $3.35 million. The purchase price was paid via a secured promissory note bearing 6% interest, as the company pivots its focus toward data center and AI infrastructure interests. The buyer is controlled by Clayton Adams, a member of the company's Board of Directors.

Value
$3.35M
Counterparty
Sanzonate Holdings LLC
5:27 PM ET 8-K
M&A Deal Fox Corp FOXA

Fox M&A Deal with Roku, Inc.

Fox Corporation shareholders approved the issuance of Class A common stock required to complete its previously announced acquisition of Roku, Inc. The transaction involves a two-step merger where Roku will become a wholly owned subsidiary of Fox. The stock issuance proposal was approved by 99.9% of the votes cast at a special meeting of Class B common stockholders.

Counterparty
Roku, Inc.
5:21 PM ET 8-K
Capital Raise Verastem, Inc. VSTM

Verastem Capital Raise of $235M

Verastem, Inc. entered into an underwriting agreement for a public offering of 30,937,500 shares of common stock and pre-funded warrants to purchase 312,503 shares. The common stock is priced at $8.00 per share, with the company expecting to receive net proceeds of approximately $234.7 million. The offering is expected to close on or about October 15, 2026.

Value
$235M
Counterparty
Jefferies LLC and Guggenheim Securities, LLC
5:19 PM ET 8-K
Regulatory Approval ImmunityBio, Inc. IBRX

ImmunityBio Regulatory Approval

The FDA has expanded the approved indication for ImmunityBio's ANKTIVA in combination with BCG to include patients with BCG-unresponsive NMIBC with papillary-only tumors. This follows the initial April 2024 approval and broadens the addressable patient population to include all patients with BCG-unresponsive NMIBC, a group that represents approximately 85% of the NMIBC population.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.